Darzalex faspro 1,800MG-30,000 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9ND7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,243
Award facts
- Contract value 100% obligated
- $78,242.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $78,242.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 27, 2026, for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This is a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp operates as the subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including military treatment facilities and veteran healthcare programs. The contract is scheduled for completion by February 18, 2026.
This award demonstrates AmerisourceBergen's role as a critical vendor within the federal medical supply chain, particularly for supporting military healthcare operations. Darzalex Faspro is a specialized oncology medication used in treating multiple myeloma, reflecting the company's portfolio that encompasses brand-name pharmaceutical products, specialty medications, and medical supplies across multiple therapeutic domains. As a child contract under the larger DLA Troop Support Medical IDC, this delivery order leverages the established relationship and streamlined procurement process that enables rapid fulfillment of essential pharmaceutical needs across federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9ND7?
SPE2DR26F9ND7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F9ND7 worth?
The government has obligated $78,243 on SPE2DR26F9ND7.
Is contract SPE2DR26F9ND7 an order under another contract?
Yes. SPE2DR26F9ND7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9ND7 competed?
The extent of competition for SPE2DR26F9ND7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award